HR7237Referred to Committee

Chemical Abortion Risk Awareness Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-01-23
Introduced
1
Cosponsors
HR
Type

Sponsor

Marlin A. Stutzman
Marlin A. Stutzman
Republican · IN · Representative
Votes with party: 97.6% (588 recorded votes)

Full profile: /officials/S001188

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2026-01-23

Source: Congress.gov

Plain-English Summary

This bill would require doctors to inform patients about the risks associated with medication-based abortion before providing the drugs, and would establish reporting requirements for any serious complications that occur. The measure would affect women seeking abortion care and healthcare providers who administer these medications. Supporters argue it increases informed consent, while opponents contend it could create barriers to accessing abortion services.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.